Macquarie Group’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,039
Closed -$4.21K 1848
2024
Q2
$4.21K Buy
+1,039
New +$4.44K ﹤0.01% 1730
2022
Q4
Sell
-331
Closed -$14K 2021
2022
Q3
$14K Sell
331
-9,109
-96% -$193K ﹤0.01% 2297
2022
Q2
$187K Sell
9,440
-5,565
-37% -$124K ﹤0.01% 1726
2022
Q1
$388K Buy
15,005
+14,283
+1,978% +$370K ﹤0.01% 1705
2021
Q4
$18K Hold
722
﹤0.01% 2421
2021
Q3
$19K Hold
722
﹤0.01% 2460
2021
Q2
$23K Hold
722
﹤0.01% 2339
2021
Q1
$25K Sell
722
-185
-20% -$6.43K ﹤0.01% 2230
2020
Q4
$29K Hold
907
﹤0.01% 2152
2020
Q3
$29K Hold
907
﹤0.01% 2082
2020
Q2
$32K Buy
+907
New +$31.5K ﹤0.01% 2036
2018
Q2
Sell
-8,200
Closed -$342K 2257
2018
Q1
$342K Buy
8,200
+500
+6% +$23.1K ﹤0.01% 1518
2017
Q4
$350K Sell
7,700
-9,700
-56% -$382K ﹤0.01% 1562
2017
Q3
$577K Buy
+17,400
New +$708K ﹤0.01% 1400

Other funds holding PETS

Macquarie Group's PETS Position: Q3 2024 in Review

Macquarie Group sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 1,039 shares — an estimated $4.21K sold.

Macquarie Group first reported a position in PETS in Q3 2017 and held it in 14 quarters. The position peaked at $577K in Q3 2017. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

  • Macquarie Group reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 1,039 PetMed Express shares in Q3 2024, an estimated $4.21K.
  • Macquarie Group first reported a position in PetMed Express in Q3 2017 and held it in 14 quarters.
  • Macquarie Group's PetMed Express position peaked at $577K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.